Interferon gamma-1b

Identification

Name
Interferon gamma-1b
Accession Number
DB00033 / 21K6M2I7AG
Groups
Actimmune
Description

Human Interferon gamma-1b (one hundred forty residues), created from E. coli. production of Actimmune is completed via fermentation of a genetically engineered Escherichia coli bacterium containing the DNA which encodes for the human protein. Purification of the product is accomplished with the aid of conventional column chromatography. The series displayed is a cDNA sequence which codes for human interferon gamma, as described by grey et. al. and now not particularly interferon gamma 1b.

Pharmacology

Pharmacodynamics

IFN gamma stimulates expression of the immunoglobulin heavy chain C gamma 3 and C gamma 2a germline transcripts in B cells. Many components of the antigen presentation pathways are also up-regulated by interferon gamma. It is also a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of type I interferons. Interferon gamma may also help the body regulate the activity of fibroblasts. By directly blocking the multiplication of fibroblasts and inhibiting the production and action of TGF-b, a potent scar-inducing molecule, Interferon gamma-1b may prevent excessive scarring.

Indication

Interferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis.

Action

Binds directly to the type II interferon gamma receptor IFNGR1, leading to a complex of IFNGR1 and IFNGR2. This activates JAK1 and JAK2 kinases which form a STAT1 docking site. This leads to STAT1 phosphorylation, nuclear translocation and initiation of gene transcription of multiple immune-related genes.